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Derivatives of amphetamines are widely abused all over
the world. After long-term use cognitive, neurophysiologi-
cal, and neuroanatomical deficits have been reported.
Neurophysiological deficits are enhanced by hyperthermia,
which itself is major mortality factor in drug abusers.
Temperature responses to injections of methamphetamine
are multiphasic and include both hypothermic and
hyperthermic phases, which are highly dependent on
ambient temperature and previous exposure to the drug.
Also, amphetamine derivatives differentially affect various
neuromediator systems, such as dopaminergic, noradre-
nergic, serotonergic. Finally, body temperature is depen-
dent on multiple thermoregulatory mechanisms and
complex neuronal circuitry.
Temperature responses to methamphetamine (Meth) at
room temperature have non-trivial dose-dependence,
which is far from being understood. Intermediate doses of
Meth cause less hyperthermia than both low and high
doses of the drug. Also, maxima of all responses have dif-
ferent latency: responses to low and high doses are vir-
tually immediate, while a response to an intermediate dose
appears to be delayed. In our previous modeling study we
demonstrated that such dose-dependence can be
explained by interaction of inhibitory and excitatory drives
induced by Meth [1]. Recently, we have published data on
the involvement of orexinergic neurotransmission in
Meth-induced temperature responses [2] where the low
dose (10 mg/kg, i.p.) of SB-334867, an antagonist of the
first type of orexin receptors (ORX1), was injected 30 min
prior to various doses of Meth. While this dose of antago-
nist clearly suppressed the response to low (1 mg/kg) and
intermediate (5 mg/kg) doses of Meth, the effect was sta-
tistically significant only at the late phase (t>60 min) of the
response to intermediate dose. At the early phase (t<60
min) any drug-related changes were marred by stress-
induced temperature fluctuations resulting from two intra-
peritoneal injections.
In a separate set of experiments, which is reported here
for the first time, a high dose of the same antagonist
(30 mg/kg, i.p.) suppressed the effect of low doses of Meth
even more, but in contrast, it significantly amplified the
responses to the higher doses (5 and 10 mg/kg) of Meth.
Since resolving this seeming controversy can have pro-
found importance by explaining cases of malignant
hyperthermia after “physiological” doses of Meth, we per-
formed a mathematical modeling study to provide its
mechanistic interpretation. We hypothesize that a specific
distribution of orexin receptors over the structures
involved in the neural control of temperature is responsi-
ble for this complex dependence of the Meth-induced
responses on the dose of orexin antagonist. To uncover
this distribution we extend our previous model [1] that
allowed us to reconstruct the activation curves of the
Meth-sensitive compartments and dose dependence of the
dynamics of the neural populations involved and to repro-
duce body temperature responses for various doses of
Meth. We use the extended model to elucidate the role of
orexinergic neurotransmission in dose-dependent tem-
perature responses to Meth.
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